Valuation: Novartis AG

Market Cap 297B 258B 241B 222B 418B 28,346B 425B 2,845B 1,114B 14,136B 1,117B 1,092B 46,625B P/E 2026 *
22.2x
P/E 2027 * 19x
Enterprise Value 331B 287B 268B 246B 464B 31,503B 472B 3,162B 1,238B 15,710B 1,241B 1,214B 51,817B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 5.32x
Free-Float
91.66%
Yield 2026 *
2.8%
Yield 2027 * 2.92%
1 day-1.38%
1 week-1.89%
Current month-1.66%
1 month-2.75%
3 months+7.42%
6 months+6.19%
Current year+13.59%
1 week 124.4
Extreme 124.4
131.5
1 month 121.06
Extreme 121.06
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 91.56
Extreme 91.56
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%-1.89%+32.18%+37.17% 297B
-2.12%-6.52%+45.57%+149.23% 1,024B
-0.66%-4.26%+48.86%+49.21% 618B
-2.05%-3.79%+25.35%+65.83% 443B
+0.68%+0.25%+38.47%+31.95% 349B
-8.96%-10.77%+3.27%+5.50% 264B
-1.37%-7.41%-3.42%-43.67% 209B
-2.85%+0.62%+25.38%+64.10% 208B
+0.41%+0.07%+14.06%+72.93% 162B
+0.18%+1.36%+6.27%-28.55% 143B
Average -1.76%-1.02%+23.60%+40.37% 371.63B
Weighted average by Cap. -1.82%-2.01%+32.21%+66.75%

Financials

2026 *2027 *
Net sales 57.58B 50.05B 46.72B 42.89B 80.88B 5,489B 82.29B 551B 216B 2,737B 216B 212B 9,028B 61.12B 53.12B 49.6B 45.53B 85.85B 5,826B 87.35B 585B 229B 2,905B 230B 225B 9,583B
Net income 13.78B 11.98B 11.18B 10.26B 19.35B 1,313B 19.69B 132B 51.64B 655B 51.76B 50.62B 2,160B 15.36B 13.35B 12.46B 11.44B 21.57B 1,464B 21.95B 147B 57.55B 730B 57.69B 56.41B 2,408B
Net Debt 33.11B 28.78B 26.87B 24.67B 46.51B 3,156B 47.32B 317B 124B 1,574B 124B 122B 5,192B 27.82B 24.18B 22.57B 20.72B 39.07B 2,651B 39.75B 266B 104B 1,322B 104B 102B 4,361B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
03/08/26 CHF 124.50 -1.66% 2,482,307
31/07/26 CHF 126.60 -0.14% 2,230,428
30/07/26 CHF 126.78 -2.28% 2,232,247
29/07/26 CHF 129.74 -0.51% 2,331,609
28/07/26 CHF 130.40 +1.46% 2,558,238
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
156.46USD
Average target price
153.99USD
Spread / Average Target
-1.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock